Your browser doesn't support javascript.
loading
Prioritising the values of potential users to promote uptake of HIV pre-exposure prophylaxis.
Traeger, Michael W; Krakower, Douglas S; Mayer, Kenneth H; Marcus, Julia L.
Affiliation
  • Traeger MW; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; The Fenway Institute, Fenway Health, Boston, MA, USA; Burnet Institute, Melbourne, VIC, Australia. Electronic address: michael.traeger@point32health.org.
  • Krakower DS; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; The Fenway Institute, Fenway Health, Boston, MA, USA; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Mayer KH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; The Fenway Institute, Fenway Health, Boston, MA, USA; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Marcus JL; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; The Fenway Institute, Fenway Health, Boston, MA, USA.
Lancet HIV ; 10(10): e690-e692, 2023 10.
Article in En | MEDLINE | ID: mdl-37573870
ABSTRACT
Benefits of pre-exposure prophylaxis (PrEP) extend beyond HIV risk reduction. Users report a range of physical, emotional, and social effects, including reduced anxiety, increased intimacy, and greater sexual satisfaction. For some people, these benefits are the primary motivation for using PrEP. To successfully engage in shared decision making about HIV prevention methods, clinicians need to be able to discuss all potential risks and benefits of PrEP. These risks and benefits include not only those related to HIV risk reduction and other clinical outcomes, but also those related to experiences and relationships that people value. However, national and international clinical resources on the provision of PrEP do not include user-reported outcomes that are values-based or reflect positive effects on personal, social, or sexual wellbeing. To better integrate the values of potential users into discussions about PrEP, clinician training programmes and clinical guidelines need to be guided by community-driven frameworks and expanded to include user-reported outcomes of PrEP use, including beneficial effects. Achieving PrEP uptake and equity goals will require an approach to PrEP provision that centres the values and desired experiences of potential users, particularly those from populations with the greatest unmet need for PrEP.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-HIV Agents / Pre-Exposure Prophylaxis Type of study: Guideline / Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: Lancet HIV Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-HIV Agents / Pre-Exposure Prophylaxis Type of study: Guideline / Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: Lancet HIV Year: 2023 Document type: Article